These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 29143802)

  • 21. Central or peripheral delivery of an adenosine A1 receptor agonist improves mechanical allodynia in a mouse model of painful diabetic neuropathy.
    Katz NK; Ryals JM; Wright DE
    Neuroscience; 2015 Jan; 285():312-23. PubMed ID: 25451280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic dexmedetomidine attenuates mechanical allodynia through extracellular sign db type 2 diabetic mice.
    Chen H; Xu X; Yang XY; Ling BY; Sun HP; Liu C; Zhang YQ; Cao H; Xu L
    Neurosci Lett; 2017 Sep; 657():126-133. PubMed ID: 28757391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiallodynic Effects of Cannabinoid Receptor 2 (CB
    Sheng WS; Chauhan P; Hu S; Prasad S; Lokensgard JR
    Pain Res Manag; 2019; 2019():1260353. PubMed ID: 31354896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Melatonin modulates neuroinflammation and oxidative stress in experimental diabetic neuropathy: effects on NF-κB and Nrf2 cascades.
    Negi G; Kumar A; Sharma SS
    J Pineal Res; 2011 Mar; 50(2):124-31. PubMed ID: 21062351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rutin ameliorates diabetic neuropathy by lowering plasma glucose and decreasing oxidative stress via Nrf2 signaling pathway in rats.
    Tian R; Yang W; Xue Q; Gao L; Huo J; Ren D; Chen X
    Eur J Pharmacol; 2016 Jan; 771():84-92. PubMed ID: 26688570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment with Sulforaphane Produces Antinociception and Improves Morphine Effects during Inflammatory Pain in Mice.
    Redondo A; Chamorro PAF; Riego G; Leánez S; Pol O
    J Pharmacol Exp Ther; 2017 Dec; 363(3):293-302. PubMed ID: 28947488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ameliorative potential of rutin in combination with nimesulide in STZ model of diabetic neuropathy: targeting Nrf2/HO-1/NF-kB and COX signalling pathway.
    Mittal R; Kumar A; Singh DP; Bishnoi M; Nag TC
    Inflammopharmacology; 2018 Jun; 26(3):755-768. PubMed ID: 29094308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Small molecule activators of the Nrf2-HO-1 antioxidant axis modulate heme metabolism and inflammation in BV2 microglia cells.
    Foresti R; Bains SK; Pitchumony TS; de Castro Brás LE; Drago F; Dubois-Randé JL; Bucolo C; Motterlini R
    Pharmacol Res; 2013 Oct; 76():132-48. PubMed ID: 23942037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteomic quantitative study of dorsal root ganglia and sciatic nerve in type 2 diabetic mice.
    Leal-Julià M; Vilches JJ; Onieva A; Verdés S; Sánchez Á; Chillón M; Navarro X; Bosch A
    Mol Metab; 2022 Jan; 55():101408. PubMed ID: 34856394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spinal cannabinoid CB1 or CB2 receptors activation attenuates mechanical allodynia in streptozotocin-induced diabetic rats.
    Gonçalves MR; da Conceição MS; Jesus CHA; Gasparin AT; Rosa ES; da Cunha JM
    Behav Pharmacol; 2022 Apr; 33(2&3):158-164. PubMed ID: 32804775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic HO-1 induction with cobalt protoporphyrin (CoPP) treatment increases oxygen consumption, activity, heat production and lowers body weight in obese melanocortin-4 receptor-deficient mice.
    Csongradi E; Docarmo JM; Dubinion JH; Vera T; Stec DE
    Int J Obes (Lond); 2012 Feb; 36(2):244-53. PubMed ID: 21467998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The selective TRPV4 channel antagonist HC-067047 attenuates mechanical allodynia in diabetic mice.
    Dias FC; Alves VS; Matias DO; Figueiredo CP; Miranda ALP; Passos GF; Costa R
    Eur J Pharmacol; 2019 Aug; 856():172408. PubMed ID: 31129158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Taurine ameliorates neuropathy via regulating NF-κB and Nrf2/HO-1 signaling cascades in diabetic rats.
    Agca CA; Tuzcu M; Hayirli A; Sahin K
    Food Chem Toxicol; 2014 Sep; 71():116-21. PubMed ID: 24907624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of type 2 cannabinoid receptor (CB2R) by selective agonists regulates the deposition and remodelling of the extracellular matrix.
    Guan T; Zhao G; Duan H; Liu Y; Zhao F
    Biomed Pharmacother; 2017 Nov; 95():1704-1709. PubMed ID: 28958132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of cannabinoid CB2 receptors reduces hyperalgesia in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.
    Fu W; Taylor BK
    Neurosci Lett; 2015 May; 595():1-6. PubMed ID: 25849525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional relevance of the cannabinoid receptor 2 - heme oxygenase pathway: a novel target for the attenuation of portal hypertension.
    Steib CJ; Gmelin L; Pfeiler S; Schewe J; Brand S; Göke B; Gerbes AL
    Life Sci; 2013 Oct; 93(16):543-51. PubMed ID: 24007798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antinociceptive effects of the selective CB2 agonist MT178 in inflammatory and chronic rodent pain models.
    Vincenzi F; Targa M; Corciulo C; Tabrizi MA; Merighi S; Gessi S; Saponaro G; Baraldi PG; Borea PA; Varani K
    Pain; 2013 Jun; 154(6):864-73. PubMed ID: 23518609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antinociceptive effects of fisetin against diabetic neuropathic pain in mice: Engagement of antioxidant mechanisms and spinal GABAA receptors.
    Zhao X; Li XL; Liu X; Wang C; Zhou DS; Ma Q; Zhou WH; Hu ZY
    Pharmacol Res; 2015 Dec; 102():286-97. PubMed ID: 26520392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heme-oxygenase induction inhibits arteriolar thrombosis in vivo: effect of the non-substrate inducer cobalt protoporphyrin.
    Johns DG; Zelent D; Ao Z; Bradley BT; Cooke A; Contino L; Hu E; Douglas SA; Jaye MC
    Eur J Pharmacol; 2009 Mar; 606(1-3):109-14. PubMed ID: 19168058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment With the Delta Opioid Agonist UFP-512 Alleviates Chronic Inflammatory and Neuropathic Pain: Mechanisms Implicated.
    Polo S; Díaz AF; Gallardo N; Leánez S; Balboni G; Pol O
    Front Pharmacol; 2019; 10():283. PubMed ID: 30971925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.